-=6 HEADLINES

Indian Market

Indian equity markets up by 0.27%

Nifty up by 16.25 pts and settle at 6009.50

Sensex up by 50.54 pts at 19764.78

Bank Nifty down by 8.65 pts at 12778.20

Global Market

European markets were up with FTSE down by 9.43 closed at 6017,CAC down by 20.18 closed at 3713 and DAX down by 25.01 closed at 7753.

Dow future was down 20.00 closed at

13311.00

WWW.EPICRESEARCH.CO 09752199966

DAILY EQUITY NEWSLETTER

4TH JANUARY 2013

HEADLINES

• Offtake target bigger challenge than

production: Coal India

• Govt may consider ordinance for

Hindustan Zinc stake sale

• IGL keen to buy ADB stake in Petronet

LNG

• Dr Reddy's Laboratories launches hair

loss tablets in US

FII’s and DII’s

CATEGORY DATE BUY SELL NET

FII 3-Jan-13 3089.48 1692.11 1397.37

DII 3-Jan-13 996.46 1902.42 -905.96

NIFTY DAILY PIVOTS

PIVOT R4 R3 R2 R1 PP S1 S2 S3 S4

NIFTY 6097 6066 6035 6022 6004 5991 5973 5942 5911

WWW.EPICRESEARCH.CO 09752199966

MARKET ANALYSIS:

The 50-unit S&P CNX Nifty moved past the psychological 6,000 level as key benchmark indices eked

out small gains. The barometer index, BSE Sensex, was provisionally up 38.66 points or 0.2%, up

59.61 points from the day's low and off 33.40 points from the day's high. The market breadth,

indicating the overall health of the market, was positive. Index heavyweight Reliance Industries (RIL)

extended intraday gains in late trade.

The BSE Sensex was up 38.66 points or 0.2% to 19,752.90.

The S&P CNX Nifty was up 12.15 points or 0.2% to 6,005.40.

Among the 30-share Sensex pack, 17 declined while the rest of them gained.

IT pivotals rose after US lawmakers early this week reached a last-minute deal to avert the fiscal cliff.

US is the biggest outsourcing market for the Indian IT firmsIT major Tata Consultancy Services rose

1.5%.India's third largest software services exporter by revenues Wipro gained 0.83%.Shares of

banking giant State Bank of India (SBI) gained 0.88% to Rs 2,469.75 after striking a 52-week high of

Rs 2,482.20 in intraday today, 3 January 2013. Dr Reddy's Laboratories advanced 2.35% after the

company said it has launched Finasteride Tablets 1 mg in the US market.

STOCKS TO WATCH

CROMPTON

ADANI

BHEL

PFC

SCRIPS IN BAN PERIOD

SUZLON

09752199966

.

EXPERT OPINION

NIFTY

Nifty looks Consolidate

Strategy: Buy on dips

Support: 5970

Resistance: 6060

BANK NIFTY

Bank Nifty looks Consolidate

Strategy: Buy on dips

Support: 12700

Resistance: 12840

.0

GAINERS AND LOOSERS

PREVIOUS PERFORMANCE

TYPE SCRIP B/S RESULT

CASH AMTEK S NOT

EXECUTED

CASH ZEE

ENTERTAINMENT B

TGT ACHEIVED

FUTURE ADANI

ENTERPRISE B

NOT EXECUTED

FUTURE HCL

TECHNOLOGIES S

NOT EXECUTED

DAILY NIFTY GAINERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHANG

E

Dr Reddys

Lab 1882.30 584.79 1837.70 44.60 2.43

Cairn India

327.50 2442.67 320.00 7.50 2.34

Bharti Airtel

328.00 3677.59 321.05 6.95 2.16

ONGC 279.80 4215.38 274.60 5.20 1.89

DLF 238.90 5511.61 235.20 3.70 1.57

DAILY NIFTY LOOSERS

SCRIPS RATE VOL.

(000)

PR.

CLOSE

NET

CHAN

GE

%

CHAN

GE

Tata Power

110.15 1607.01 112.00 -1.85 -1.65

Lupin 608.85 475.31 614.90 -6.05 -0.98

PNB 896.80 587.50 905.50 -8.70 -0.96

Sun Pharma

Inds. 733.85 520.44 740.90 -7.05 -0.95

Hero MotoCorp

1887.95 334.61 1905.35 -17.40 -0.91

.

MARKET CALLS

CASH

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

BHARTI AIRTEL BUY 328.90 330.90 333.90 326.90

ICICI BANK SELL 1168.00 1158.00 1145.00 1178.00

FUTURE

SCRIPS ACTION LEVEL 1ST

TARGET 2ND

TARGET STOP LOSS

ALLAHBAD BANK BUY 181.30 182.30 183.80 180.30

ADANI ENETERPRISES

SELL 282.00 281.00 279.50 283.00

Disclaimer

The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most.

Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable.

This material is for personal information and based upon it & takes no responsibility

The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE.

The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer.

All Rights Reserved. Investment in equity & bullion market has its own risks.

We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.